To further explore the molecular mechanism underlying KRAS-mutant–mediated platinum resistance in lung cancer, we performed RNA-Seq analysis in control and KRAS G12V–expressing NCI-H522 cells. This evidence concerns the gene KRAS and lung carcinoma.